|
Volumn 275, Issue 49, 2000, Pages 38417-38426
|
Styelin D, an extensively modified antimicrobial peptide from ascidian hemocytes
|
Author keywords
[No Author keywords available]
|
Indexed keywords
6 BROMOTRYPTOPHAN;
ANTIINFECTIVE AGENT;
ARGININE DERIVATIVE;
DOPA;
LYSINE DERIVATIVE;
PEPTIDE;
PHENYLALANINE DERIVATIVE;
STYELIN D;
TRYPTOPHAN DERIVATIVE;
UNCLASSIFIED DRUG;
AMINO ACID SEQUENCE;
ANTIMICROBIAL ACTIVITY;
ARTICLE;
ASCIDIACEA;
BLOOD CELL;
CHEMICAL MODIFICATION;
CONTROLLED STUDY;
CYTOTOXICITY;
DRUG STRUCTURE;
GENETIC HETEROGENEITY;
GRAM NEGATIVE BACTERIUM;
GRAM POSITIVE BACTERIUM;
HEMOLYSIS;
HYDROXYLATION;
IMMUNE RESPONSE;
NONHUMAN;
PH;
PRIORITY JOURNAL;
PROTEIN MODIFICATION;
PROTEIN PROCESSING;
PROTEIN SECONDARY STRUCTURE;
SALINITY;
AMINO ACID SEQUENCE;
ANIMALS;
ANTI-BACTERIAL AGENTS;
CELL MEMBRANE PERMEABILITY;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
DIHYDROXYPHENYLALANINE;
ESCHERICHIA COLI;
GAS CHROMATOGRAPHY-MASS SPECTROMETRY;
HEMOCYTES;
MOLECULAR SEQUENCE DATA;
PEPTIDE FRAGMENTS;
PROTEINS;
TRYPTOPHAN;
UROCHORDATA;
ASCIDIA;
ASCIDIACEA;
BACTERIA (MICROORGANISMS);
CLAVA;
EUKARYOTA;
NEGIBACTERIA;
POSIBACTERIA;
STYELA CLAVA;
|
EID: 0034623953
PISSN: 00219258
EISSN: None
Source Type: Journal
DOI: 10.1074/jbc.M006762200 Document Type: Article |
Times cited : (100)
|
References (54)
|